| Brain pyrimidine nucleotide synthesis and Alzheimer disease A Pesini, E Iglesias, MP Bayona-Bafaluy, N Garrido-Pérez, P Meade, ... Aging (Albany NY) 11 (19), 8433, 2019 | 30 | 2019 |
| OXPHOS, pyrimidine nucleotides, and Alzheimer's disease: a pharmacogenomics approach A Pesini, E Iglesias, N Garrido, MP Bayona-Bafaluy, J Montoya, ... Journal of Alzheimer's Disease 42 (1), 87-96, 2014 | 23 | 2014 |
| Mutant CHCHD10 causes an extensive metabolic rewiring that precedes OXPHOS dysfunction in a murine model of mitochondrial cardiomyopathy NM Sayles, N Southwell, K McAvoy, K Kim, A Pesini, CJ Anderson, ... Cell reports 38 (10), 2022 | 16 | 2022 |
| Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease E Iglesias, A Pesini, N Garrido-Perez, P Meade, MP Bayona-Bafaluy, ... Ageing Research Reviews 45, 24-32, 2018 | 12 | 2018 |
| Uridine prevents negative effects of OXPHOS xenobiotics on dopaminergic neuronal differentiation E Iglesias, MP Bayona-Bafaluy, A Pesini, N Garrido-Pérez, P Meade, ... Cells 8 (11), 1407, 2019 | 9 | 2019 |
| Mechanisms and therapeutic effects of benzoquinone ring analogs in primary CoQ deficiencies A Pesini, A Hidalgo-Gutierrez, CM Quinzii Antioxidants 11 (4), 665, 2022 | 8 | 2022 |
| Whole-exome sequencing study of fibroblasts derived from patients with cerebellar ataxia referred to investigate CoQ10 deficiency E Monfrini, A Pesini, F Biella, CFR Sobreira, V Emmanuele, G Brescia, ... Neurology: Genetics 9 (2), e200058, 2023 | 1 | 2023 |
| Abnormalities of lipid metabolism in neuronal models of CoQ10 deficiency (S49. 004) A Pesini, G Monzio-Compagnoni, E Barriocanal-Casado, ... Neurology 100 (17 Supplement 2), 2023 | | 2023 |
